{"DataElement":{"publicId":"3243070","version":"1","preferredName":"Gynecologic Neoplasm Characteristic Type","preferredDefinition":"the pathologic feature or configuration related to gynecologic tumor characteristics.","longName":"3243065v1.0:3243066v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3243065","version":"1","preferredName":"Gynecologic Neoplasm Characteristic","preferredDefinition":"information related to gynecologic tumor characteristics.","longName":"2206690v1.0:2177580v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177580","version":"1","preferredName":"Characteristics","preferredDefinition":"Characteristics; distinguishing qualities of a person, object, or substance.","longName":"Characteristics","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-519C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-3962-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3243066","version":"1","preferredName":"Gynecologic Tumor Characteristics Type","preferredDefinition":"the pathologic feature or configuration of a tumor or tumor specimen related to women's health issues.","longName":"3243066v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"C","valueDescription":"C-Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","ValueMeaning":{"publicId":"3243067","version":"1","preferredName":"C-Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","longName":"3243067","preferredDefinition":"C-Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-3991-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-39AA-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"B","valueDescription":"B-Stage II endometrial carcinoma (any histology), with or without risk factors","ValueMeaning":{"publicId":"3243068","version":"1","preferredName":"B-Stage II endometrial carcinoma (any histology), with or without risk factors","longName":"3243068","preferredDefinition":"B-Stage II endometrial carcinoma (any histology), with or without risk factors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-39B4-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-39CD-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"A","valueDescription":"A-Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","ValueMeaning":{"publicId":"3243069","version":"1","preferredName":"A-Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","longName":"3243069","preferredDefinition":"A-Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-39D7-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-39F0-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","valueDescription":"Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","ValueMeaning":{"publicId":"3243080","version":"1","preferredName":"Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","longName":"3243080","preferredDefinition":"Stage I endometriod endomet. ca., high-intermed risk, (+) or (-) cytology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-3ABB-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-3AD4-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Stage II endometrial carcinoma (any histology), with or without risk factors","valueDescription":"Stage II endometrial carcinoma (any histology), with or without risk factors","ValueMeaning":{"publicId":"3243081","version":"1","preferredName":"Stage II endometrial carcinoma (any histology), with or without risk factors","longName":"3243081","preferredDefinition":"Stage II endometrial carcinoma (any histology), with or without risk factors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-3ADE-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-3AF7-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","valueDescription":"Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","ValueMeaning":{"publicId":"3243082","version":"1","preferredName":"Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","longName":"3243082","preferredDefinition":"Stage I-II serous or clear cell endomet. ca with neg. cytology, w/ or w/o risk","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-3B01-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A537147F-3B1A-B22A-E040-BB89AD430A3F","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"ONEDATA","dateModified":"2011-06-08","deletedIndicator":"No"},{"value":"Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","valueDescription":"Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","ValueMeaning":{"publicId":"3253935","version":"1","preferredName":"Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","longName":"3253935","preferredDefinition":"Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A87119DA-A1C6-AFB5-E040-BB89AD431308","latestVersionIndicator":"Yes","beginDate":"2011-07-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A87119DA-A1DF-AFB5-E040-BB89AD431308","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-19","modifiedBy":"ONEDATA","dateModified":"2011-07-19","deletedIndicator":"No"},{"value":"A","valueDescription":"A-Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","ValueMeaning":{"publicId":"3253931","version":"1","preferredName":"A-Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","longName":"3253931","preferredDefinition":"A-Stage I endometrioid endomet. ca., high-intermed risk, (+) or (-) cytology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8711155-CDC4-B735-E040-BB89AD437D69","latestVersionIndicator":"Yes","beginDate":"2011-07-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8711155-CDDD-B735-E040-BB89AD437D69","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-19","modifiedBy":"ONEDATA","dateModified":"2011-07-19","deletedIndicator":"No"},{"value":"Stage II endometrioid endometrial cancer","valueDescription":"Stage II endometrioid endometrial cancer","ValueMeaning":{"publicId":"7039068","version":"1","preferredName":"Stage II endometrioid endometrial cancer","longName":"7039068","preferredDefinition":"Stage II endometrioid endometrial cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"968895A5-C966-4E5E-E053-F662850ACE0B","latestVersionIndicator":"Yes","beginDate":"2019-11-04","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-11-04","modifiedBy":"ONEDATA","dateModified":"2019-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"968895A5-C97F-4E5E-E053-F662850ACE0B","beginDate":"2019-11-04","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-11-04","modifiedBy":"ONEDATA","dateModified":"2019-11-04","deletedIndicator":"No"},{"value":"Stage I endometrioid endometrial cancer","valueDescription":"Stage I endometrioid endometrial cancer","ValueMeaning":{"publicId":"7039069","version":"1","preferredName":"Stage I endometrioid endometrial cancer","longName":"7039069","preferredDefinition":"Stage I endometrioid endometrial cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"968895A5-C989-4E5E-E053-F662850ACE0B","latestVersionIndicator":"Yes","beginDate":"2019-11-04","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-11-04","modifiedBy":"ONEDATA","dateModified":"2019-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"968895A5-C9A2-4E5E-E053-F662850ACE0B","beginDate":"2019-11-04","endDate":null,"createdBy":"SARAHB","dateCreated":"2019-11-04","modifiedBy":"ONEDATA","dateModified":"2019-11-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A537147F-397B-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"SARAHB","dateModified":"2019-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"}]}],"AlternateNames":[{"name":"3243065v1.0:3243066v1.0","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Which of the categories below","type":"Preferred Question Text","description":"Which of the categories below describes the patient's tumor characteristics","url":null,"context":"CTEP"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A537147F-39FA-B22A-E040-BB89AD430A3F","latestVersionIndicator":"Yes","beginDate":"2011-06-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-08","modifiedBy":"FORMBUILDER","dateModified":"2014-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}